Best life science marketing agency, and the reviewer who is not your buyer

A life science marketing agency sells to an audience that reads for a living. The buyer of a reagent, an instrument, a contract research service or a lab informatics platform is usually a scientist who will check your claim, and the person who signs the order is usually somebody in procurement who will not. An agency that can write copy a scientist does not dismiss, while still producing something procurement can approve, is rare, and that single capability should decide your shortlist.

This page is about the research and tools side of life sciences: reagents and consumables, instruments, diagnostics, contract research and manufacturing, and laboratory software. If your work is promotional material for an approved drug, or marketing a hospital, clinic or health plan, that is a different market with a different approval chain, and the four kinds of shop are mapped in health care marketing agencies and the review chain. We are deliberately not answering that question twice.

Five businesses inside one phrase

You sell	Your real marketing problem	What the agency has to be able to do
Reagents and consumables	Thousands of catalogue items, each with its own search demand and a long tail of application queries	Catalogue scale content, application notes, and search work on a very large product set
Instruments and capital equipment	A six figure purchase with a committee, a demo cycle and a two year horizon	Technical content that supports a long cycle, plus specification comparison that survives a scientist reading it
Contract research or manufacturing	A trust purchase where capability, capacity and compliance are the product	Credibility content: method detail, facility and capacity specifics, and the ability to say what you do not do
Diagnostics	Two audiences, the clinician and the laboratory, under claim restrictions	Claim discipline, and the judgement to know which statements need a reference
Lab software and informatics	A software sale into a scientific workflow nobody wants disrupted	Workflow literate content and integration detail, which is closer to technical software marketing than to life sciences

Agencies specialise within this list far more than their websites suggest. A shop that is excellent at catalogue scale reagent content is often poor at a capital equipment committee sale, and the reverse. Ask which of these five rows is most of their revenue, and the honest ones will tell you.

The criterion to rank agencies on, applied to everybody

The checkable criterion is this: can the agency show a piece of published work, with the scientist's name on it, that a working scientist in that field agreed to be associated with? A co authored application note, a webinar with a named academic, a method piece a customer put their name to. It is checkable because the name is on it and the person is findable. It is a hard test to fake, and it separates the agencies that have a relationship with the scientific community from the ones that write about it.

Ranked on that criterion, specialist life science agencies come first, because that work is their whole positioning. Technical business to business agencies without category experience come second and are often a better value purchase for the software row above. Generalist agencies come last, not because they are bad, but because the cost of teaching them your field is paid by you, in review cycles.

The reviewer who decides your timeline

The thing that surprises first time buyers is that the slowest part of the work is not writing, design or media. It is internal scientific review. A piece of content about a method passes through somebody who is professionally obliged to be sceptical, and that person is not the buyer, is not in marketing, and has their own job. Every agency that has worked in this category knows this; the ones that have not will quote a timeline that assumes marketing approves its own copy.

• Ask for an average review cycle count per asset from a comparable client, and how they plan for it. Two rounds and five rounds are different projects at different prices.
• Ask who on their side can argue with a scientist productively. Not a PhD on the masthead. The person who will be on the call.
• Name your reviewer before the contract and get their capacity in writing. Most delays in this category are a single busy scientist with no time allocated to review, and that is your problem to solve rather than the agency's.
• Agree what needs a citation and what does not, as a written rule. This one decision removes most review friction, because the argument is usually about evidence rather than about style.

What to ask for instead of a credentials deck

• A redacted review log from a real project: rounds, elapsed time, and what actually changed between versions.
• One piece of content whose performance they can show over twelve months, not a campaign highlight.
• The named people on your account and the share of their week you are buying.
• Their position on what they will not claim on your behalf, in writing. An agency with no such position has not been tested yet.
• How they handle a conference calendar, because in this category a large share of the year's demand is attached to a handful of dates.

The writing craft itself, which is the part most agencies underestimate, is worked through in writing for scientists, buyers and reviewers at the same time.

Where this category is losing visibility without noticing

Scientific buyers were early and heavy adopters of assistants for literature and product questions, which makes this category unusual: a meaningful share of the top of the funnel now happens inside a conversation rather than on a results page. Somebody asks which suppliers make an antibody for a target, which instrument is used for an assay, or which contract research organisation handles a particular study type, and ChatGPT, Gemini, Perplexity, Claude or Google's AI Overviews answer with named companies and lean on published method content, papers and documentation rather than on product pages.

This is an unusually good fit for a life science supplier, because the content that earns those citations is the content this category already produces: application notes, methods, specifications and documentation. Most of it is published as PDFs behind forms, which makes it invisible to exactly the systems now answering the question. The measurable version of the problem is simply which suppliers get named for your assays and your instruments. AI Knows Us reads those five surfaces and reports which companies were named and which sources each answer drew on, and the free scan on your own domain needs no account. Growth at 299 dollars a month is the cheapest published tier that reads all five. Where a rival wins: Ahrefs Brand Radar publishes market scale prompt volume we do not, quoting "493 million+ search-backed prompts" on ahrefs.com/brand-radar read 21 October 2026, although the same page is internally inconsistent about Claude, listing "AI Overviews, AI Mode, ChatGPT, Perplexity, Gemini, Copilot" in its FAQ while its pricing section says "All platforms (Claude available)". We report both readings rather than the convenient one.

Questions life science marketers ask before hiring an agency

Do we need an agency that only does life sciences?

For reagents, instruments, diagnostics and contract research, usually yes, because the review process is the project and category experience is what shortens it. For laboratory software, a strong technical business to business agency is often the better buy.

Should application notes sit behind a form?

Put the method and the result in a public page and keep the form for the deeper asset, the dataset or the protocol file. Gating the whole thing removes it from search and from assistant answers at once, which is a high price for a contact record.

How much of the budget should go to conferences?

Less than it traditionally does, and the change to make is not the booth. It is publishing the content of your conference presence where somebody who did not attend can find it, which is where most of that spend currently evaporates.

Who should own technical accuracy, us or the agency?

You, always, with a named reviewer and allocated time. An agency that offers to own scientific accuracy is offering something it cannot carry, and the pages that result are the ones your own scientists quietly disown.

When can marketing be judged in a capital equipment sale?

Pipeline influence is the first outcome you can measure, and how soon it shows depends on competition, your offer and your budget; revenue follows on your own sales cycle, which for a six figure instrument is commonly eighteen months or more. Agree the interim measures, usually qualified demo requests and specification page engagement, before the work starts.